{
    "clinical_study": {
        "@rank": "139511", 
        "arm_group": [
            {
                "arm_group_label": "Ceftolozane/tazobactam", 
                "arm_group_type": "Experimental", 
                "description": "IV ceftolozane/tazobactam 3000 mg q8h"
            }, 
            {
                "arm_group_label": "Piperacillin/tazobactam", 
                "arm_group_type": "Active Comparator", 
                "description": "Piperacillin/tazobactam 4500 mg q6h"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a Phase 3, multicenter, prospective, randomized, open-label, study of IV\n      ceftolozane/tazobactam vs. IV piperacillin/tazobactam in the treatment of VAP in adult\n      patients."
        }, 
        "brief_title": "Study of Intravenous Ceftolozane/Tazobactam vs.Piperacillin/Tazobactam in Ventilator Associated Pneumonia", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Ventilator-associated Pneumonia (VAP)", 
        "condition_browse": {
            "mesh_term": [
                "Pneumonia", 
                "Pneumonia, Ventilator-Associated"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key Inclusion Criteria:\n\n          -  Patient has received mechanical ventilation for >48 hours\n\n          -  APACHE score of 11-35\n\n          -  Presence of a new or progressive infiltrate on chest x-ray\n\n          -  Presence of clinical criteria consistent with VAP\n\n        Key Exclusion Criteria:\n\n          -  History of moderate or severe hypersensitivity reactions to beta-lactam antibiotics\n\n          -  Known end stage renal disease or requirement for dialysis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "4", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01853982", 
            "org_study_id": "CXA-NP-11-08"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ceftolozane/tazobactam", 
                "intervention_name": "Ceftolozane/tazobactam", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Piperacillin/tazobactam", 
                "intervention_name": "Piperacillin/tazobactam", 
                "intervention_type": "Drug", 
                "other_name": "Zosyn"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Piperacillin", 
                "Penicillanic Acid", 
                "Piperacillin-tazobactam combination product", 
                "Cephalosporins", 
                "Tazobactam"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 28, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Duluth", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jamaica", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Abington", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Herston", 
                        "country": "Australia", 
                        "state": "Queensland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meadowbrook", 
                        "country": "Australia", 
                        "state": "Queensland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nambour", 
                        "country": "Australia", 
                        "state": "Queensland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southport", 
                        "country": "Australia", 
                        "state": "Queensland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woolloongabba", 
                        "country": "Australia", 
                        "state": "Queensland"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auckland", 
                        "country": "New Zealand"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Christchurch", 
                        "country": "New Zealand"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wellington", 
                        "country": "New Zealand"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Australia", 
                "New Zealand"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "CXA-NP-11-08:(VECTOR) A Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Intravenous Ceftolozane/Tazobactam With That of Piperacillin/Tazobactam in Ventilator Associated Pneumonia", 
        "overall_official": {
            "affiliation": "Cubist Pharmaceuticals", 
            "last_name": "Obiamiwe Umeh, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Clinical response at the End of Therapy visit in the mITT population", 
            "safety_issue": "No", 
            "time_frame": "24 hours after last dose of study drug"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01853982"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cubist Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cubist Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014", 
        "why_stopped": "Reason is not required"
    }
}